Instrument Inactif

Autres langues Serendex Pharmaceuticals A/S

Actions

SENDEX

DK0060563427

Recherche biotechnologique et médicale

Autres langues

12/07/16	Serendex Pharmaceuticals A/S : Minutes of Serendex’s Extraordinary General Meeting 2016
21/06/16	Serendex Pharmaceuticals A/S : Savara Pharmaceuticals acquires Serendex
25/05/16	Serendex Pharmaceuticals A/S : First patient dosed in Serendex’s pivotal trial for PAP
12/05/16	Serendex Pharmaceuticals A/S : signs license agreement with Japanese partner
02/05/16	Serendex Pharmaceuticals A/S : Delisting of Serendex as of 4 May 2016
29/04/16	Serendex Pharmaceuticals A/S : Minutes of Serendex’s Ordinary General Meeting 2016
28/04/16	Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Ordinary General Meeting
04/04/16	Serendex Pharmaceuticals A/S : releases Annual Report 2015
08/03/16	Serendex Pharmaceuticals A/S : secures credit facility
07/03/16	Serendex Pharmaceuticals A/S : to delist from Oslo Axess; to terminate market making agreement with NORNE A/S
19/02/16	Serendex Pharmaceuticals A/S : pivotal clinical trial for PAP approved in Japan
19/02/16	Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016
10/02/16	Serendex Pharmaceuticals A/S : Correction to Serendex Financial Calendar 2016
10/02/16	Serendex Pharmaceuticals A/S : Minutes from Serendex’s Extraordinary General Meeting
09/02/16	Serendex Pharmaceuticals A/S : Brief Account of Serendex’s Extraordinary General Meeting
28/01/16	Serendex Pharmaceuticals A/S : establishes a warrant programme for the company’s employees
25/01/16	Serendex Pharmaceuticals A/S : Extraordinary General Meeting – correction to “The Complete Proposals”
13/01/16	Serendex Pharmaceuticals A/S : New share capital registered – correction of previously announced result of the issue
06/01/16	Serendex Pharmaceuticals A/S : Primary insider notification
06/01/16	Serendex Pharmaceuticals A/S : The Rights Issue in Serendex Pharmaceuticals A/S was fully subscribed
06/01/16	Serendex Pharmaceuticals A/S : Major shareholding notification
18/12/15	Serendex Pharmaceuticals A/S : to potentially enter into license agreement with strategic partner for Japan
10/12/15	Serendex Pharmaceuticals A/S : Rights issue – record date information
10/12/15	Serendex Pharmaceuticals A/S : Strategic review and future financing
03/12/15	Serendex Pharmaceuticals A/S : Primary insider notification